-
Nuplazid, a drug for hallucinations and delusions associated with Parkinson’s disease, failed two clinical trials. In a third trial, under a revised…
-
The agency says the labels for testosterone drugs must state they aren't approved to fight aging and may increase the risk for heart attacks and strokes.